ATE290386T1 - Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen - Google Patents

Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen

Info

Publication number
ATE290386T1
ATE290386T1 AT96917988T AT96917988T ATE290386T1 AT E290386 T1 ATE290386 T1 AT E290386T1 AT 96917988 T AT96917988 T AT 96917988T AT 96917988 T AT96917988 T AT 96917988T AT E290386 T1 ATE290386 T1 AT E290386T1
Authority
AT
Austria
Prior art keywords
diglucosylamine
glucose
composition
beta
organism
Prior art date
Application number
AT96917988T
Other languages
English (en)
Inventor
Clairmont G Drube
Original Assignee
Biodynamics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodynamics Pharmaceuticals In filed Critical Biodynamics Pharmaceuticals In
Application granted granted Critical
Publication of ATE290386T1 publication Critical patent/ATE290386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96917988T 1995-06-06 1996-06-06 Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen ATE290386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/470,501 US5631245A (en) 1995-06-06 1995-06-06 Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
PCT/US1996/008599 WO1996039153A2 (en) 1995-06-06 1996-06-06 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis

Publications (1)

Publication Number Publication Date
ATE290386T1 true ATE290386T1 (de) 2005-03-15

Family

ID=23867867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917988T ATE290386T1 (de) 1995-06-06 1996-06-06 Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen

Country Status (13)

Country Link
US (2) US5631245A (de)
EP (1) EP0831847B1 (de)
JP (1) JPH11506766A (de)
CN (1) CN1190891A (de)
AT (1) ATE290386T1 (de)
AU (1) AU721709B2 (de)
BR (1) BR9608435A (de)
CA (1) CA2222915A1 (de)
DE (1) DE69634434D1 (de)
HU (1) HUP9802541A2 (de)
IL (1) IL122401A0 (de)
PE (1) PE18898A1 (de)
WO (1) WO1996039153A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DK1651161T3 (da) * 2003-08-07 2012-01-30 Healor Ltd Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
EP1660089A1 (de) * 2003-08-22 2006-05-31 Schering Aktiengesellschaft Chemokin-hemmende piperazin-derivate und ihre verwendung zur behandlung von myokarditis
WO2007026356A2 (en) * 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
TR201807756T4 (tr) * 2006-09-26 2018-06-21 Infectious Disease Res Inst Sentetik adjuvan içeren aşı bileşimi.
GB0622688D0 (en) * 2006-11-14 2006-12-27 Diosamine Dev Corp Novel compounds
GB2450088A (en) * 2007-06-11 2008-12-17 Diosamine Dev Corp Optionally modified monosaccharides with imine/iminium or glycosidic amine/ammonium group for use in modifying the level of cytokines & in therapy
US20100310542A1 (en) * 2007-07-30 2010-12-09 Healor Ltd. Pharmaceutical Compositions for treating wouds and related methods
KR101098581B1 (ko) 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination
AU2011204425A1 (en) 2010-01-11 2012-08-02 Healor Ltd. Method for treatment of inflammatory disease and disorder
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US10953025B2 (en) * 2011-07-14 2021-03-23 Able Cerebral, Llc Composition, device and method for delayed and sustained release of brain energy molecules
CN103945832B (zh) * 2011-07-14 2017-03-29 能脑有限责任公司 用于脑能量分子延迟释放和持续释放的组合物，装置及方法
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE446299B (sv) * 1978-04-11 1986-09-01 Kureha Chemical Ind Co Ltd Medicinsk komposition innehallande ett derivat av para-aminobensoesyra som aktiv bestandsdel
JPS56142211A (en) * 1980-04-09 1981-11-06 Riken Vitamin Co Ltd Production of enteric preparation
DE3346623A1 (de) * 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
US4695590A (en) * 1986-05-05 1987-09-22 California Health Technologies Method for retarding aging
US5219843A (en) * 1987-09-23 1993-06-15 Sandoz Ltd. Saccharide derivatives
US5177062A (en) * 1988-08-09 1993-01-05 Mect Corporation Method for treating immune complex diseases with n-acetylneuraminic acid
US5248668A (en) * 1991-05-16 1993-09-28 Wintek Consulting Ltd. Use of purpurogallin and glycosides thereof in treating ischemia in mammals
ATE156707T1 (de) * 1991-06-21 1997-08-15 Ilsan Ilac Ve Hammaddeleri San Neues galenisches verfahren für omeprazol enthaltende pellets
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US5872111A (en) * 1997-05-19 1999-02-16 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycosylamide surfactants

Also Published As

Publication number Publication date
HUP9802541A2 (hu) 1999-02-01
AU6035696A (en) 1996-12-24
CN1190891A (zh) 1998-08-19
CA2222915A1 (en) 1996-12-12
BR9608435A (pt) 2000-05-09
IL122401A0 (en) 1998-06-15
US5631245A (en) 1997-05-20
EP0831847B1 (de) 2005-03-09
AU721709B2 (en) 2000-07-13
PE18898A1 (es) 1998-04-13
EP0831847A2 (de) 1998-04-01
DE69634434D1 (de) 2005-04-14
MX9709751A (es) 1998-07-31
JPH11506766A (ja) 1999-06-15
US6770635B1 (en) 2004-08-03
WO1996039153A2 (en) 1996-12-12
WO1996039153A3 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
ATE290386T1 (de) Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
CA2260777A1 (en) Pentafluorobenzenesulfonamides and analogs
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
GEP20053421B (en) Substituted Pyrazoles As P38 Kinase Inhibitors, Method for Their Production and Pharmaceutical Compositions Containing Them
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
DE69531502D1 (de) Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen
GB2075341B (en) Pharmaceutical compositions
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
FI854926A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
IE43693L (en) Androstane derivatives
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
RU94031479A (ru) Новое применение производных аминокислот, способ лечения, фармацевтическая композиция
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
CA2031897A1 (en) Carbamoyl derivatives
FR2384791A1 (fr) Nouveaux derives d'everninomicine, leur procede de preparation et compositions pharmaceutiques contenant lesdits derives
AR004353A1 (es) Metodo para medicamentar el sistema de control inflamatorio y reacciones inflamatorias adversas y para fabricar compuestos para el tratamiento de lapatologia de reacciones inflamatorias adversas.
RU94035756A (ru) Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция
FR2414333A2 (fr) Composition pharmaceutique contenant comme ingredient actif la d-2-bromo 6-methyl-8b-(morpholinocarbonyoxymethyl)-ergoline, utile notamment pour le traitement de l'asthme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties